Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
My ears pricked up at this point too.... very happy with the answer!!
only with SNG would i be complaining about top slicing at 300%...
only wish i had topped up more at 35p last week... and held on this morning without selling a slice.
amazing rollercoaster since march, but i'm glad its paid off well for all concerned. where does it stop though?!?!?
https://www.londonstockexchange.com/news-article/tidm/headline/14615915
Yes. Finally 100 patients in the hospital trial. Results in July, later than originally expected but I’m remaining patient (no pun intended)
Hopefully the ‘at home trial’ has a quicker uptake. I’m looking forward to seeing positive results on SNG001. Covid19 isn’t going away completely and we need some form of treatment. Albeit a combination of drugs possibly.
Southampton, UK - 28 May 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, is pleased to announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients has now been completed.
The COVID-19 study
Synairgen's clinical trial in COVID-19 patients (SG016) is a double-blind, placebo-controlled trial. The 220 patient trial comprises 100 patients initiated in hospital and 120 patients initiated in the home setting. The patients participating in the hospital setting have been recruited across a number of NHS trusts and the trial has been adopted by the NIHR Respiratory Translational Research Collaboration which is comprised of leading centres in respiratory medicine in the UK whose internationally recognised experts are working together to accelerate development and discovery for COVID-19. A successful outcome will inform onwards progression of SNG001 in COVID-19 patients. Results from the hospital setting are expected in July 2020, as announced in the Company's Preliminary Results statement on 26 May 2020.
Richard Marsden, CEO of Synairgen, commented: "We are pleased to have now completed recruitment in this important study, with initial trial data expected in July 2020. A successful outcome from this trial could be a critical step towards strengthening the fight against the COVID-19 pandemic."
Full RNS
https://yoizer.com/?n=14555555
https://m.londonstockexchange.com/exchange/mobile/news/detail/14529609.html
So in respect to the placing. Does this keep the SP at current levels until they are approved by holders and then released? FDA approval in the interim would obviously cause an increase but not taking this into account. What do folks see as the effect of the placing on SP.
ChrisToffer
https://m.londonstockexchange.com/exchange/mobile/news/detail/14524659.html
Hopefully link shows. I’m new to board in last few weeks.
forgive the amateur question, i've not been long in this share dealing, and got into SNG close to the top end a couple of weeks ago... so i've been an avid reader of this chat,
im just wondering how the shares at 35p will affect the sp, if at all.
apologies if thats a silly question..